FAR、TG/HDL-C比值与急性心肌梗死合并心力衰竭患者预后的关系  

Relationship between FAR,TG/HDL-C Ratio and Prognosis in Patients with Acute Myocardial Infarction Combined with Heart Failure

作　　者：王海云[1] 李雅敏[1] 闫树凤[1] 孙黎黎[1] 王溪[1] WANG Hai-yun;LI Ya-min;YAN Shu-feng;SUN Li-li;WANG Xi(Department of Emergency,Beijing Anzhen Hospital Affiliated to Capital Medical University,Beijing,100029,China)

机构地区：[1]首都医科大学附属北京安贞医院急诊科,北京100029

出　　处：《现代生物医学进展》2024年第20期3848-3850,共3页Progress in Modern Biomedicine

基　　金：北京市医管局重点医学发展计划(ZYLX201710)。

摘　　要：目的:探讨纤维蛋白原/白蛋白比值(FAR)、甘油三酯与高密度脂蛋白胆固醇(TG/HDL-C)比值与急性心肌梗死(AMI)合并心力衰竭(HF)患者预后的关系。方法:回顾性收集我院急诊科收治的178例AMI合并HF患者的资料纳入HF组,根据预后分为不良预后亚组(61例)和良好预后亚组(117例),多因素Logistic回归分析AMI合并HF患者不良预后的影响因素。结果:与良好预后亚组比较,不良预后亚组FAR、TG/HDL-C比值升高(P<0.05)。AMI合并HF患者不良预后的独立危险因素为FAR升高、TG/HDL-C比值升高、B型利钠肽(BNP)升高,独立保护因素为LVEF升高(P<0.05)。结论:FAR、TG/HDL-C比值升高与AMI合并HF患者不良预后密切相关。Objective:To investigate the relationship between fibrinogen/albumin(FAR)ratio,triglyceride/high density lipoprotein cholesterol(TG/HDL-C)ratio and prognosis in patients with acute myocardial infarction(AMI)combined with heart failure(HF).Methods:The data of 178 patients with AMI combine with HF admitted to the emergency department of our hospital were retrospectively collected and included in HF group,patients were divided into poor prognosis subgroup(61 cases)and good prognosis subgroup(117 cases)according to the prognosis,the influence factor of poor prognosis in patients with AMI combine with HF were analyzed by multivariate Logistic regression analysis.Results:Compared with good prognosis subgroup,the FAR and TG/HDL-C ratio in poor prognosis subgroup increased(P<0.05).The independent risk factors of poor prognosis in patients with AMI combined with HF were increased FAR,increased TG/HDL-C ratio and increased B-type natriuretic peptide(BNP),and the independent protective factor was increased LVEF(P<0.05).Conclusion:The increase of FAR and TG/HDL-C ratio is closely relate to poor prognosis of patients with AMI combined with HF.

关 键 词：急性心肌梗死 心力衰竭 FAR TG/HDL-C比值 预后 

分 类 号：R542.22[医药卫生—心血管疾病] R541.61[医药卫生—内科学]